StockSelector.com
  Research, Select, & Monitor Wednesday, October 23, 2019 3:54:39 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Onconova Therapeutics, Inc.$0.86($.25)(22.52%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Onconova Therapeutics, Inc. has an overall rank of 6692 out of 7140 stocks based on 6 positive rankings and 8 negative rankings.

Positive Rankings
Estimated Revenue Growth
Onconova Therapeutics rank is 62
Oversold RSI
The 14 Day Relative-Strength Index for Onconova Therapeutics is 26.0. An RSI below 30 indicates the stock is oversold. Among companies with a low RSI, Onconova Therapeutics is ranked 75.
Up EPS Surprise
Onconova Therapeutics beat the consensus earnings estimate when it last reported quarterly earnings.
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Onconova Therapeutics is ranked 533.
10 Day Gain
Onconova Therapeutics rank is 701
Price-to-Book
Onconova Therapeutics rank is 1073
Negative Rankings
Negative Cash Growth
Onconova Therapeutics rank is 51
90 Day Loss
Onconova Therapeutics rank is 85
Negative ROE
Onconova Therapeutics rank is 105
Negative Revenue Growth
Onconova Therapeutics rank is 117
Negative Net Margin
Onconova Therapeutics rank is 194
Negative ROA
Onconova Therapeutics rank is 244
Debt-to-Equity
Onconova Therapeutics rank is 1464
Price-to-Sales
Onconova Therapeutics rank is 2223







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.